i2020 Accelerator
Overview
i2020 Accelerator is an accelerator program backed by the San Diego-based venture company Torrey Pines Investment that invests in early-stage drug discovery platforms. It focuses on therapeutic areas including immunology, inflammation, oncology, CNS, and infectious diseases.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Brenig Therapeutics | Apr 2021 | Seed | Co-investor |
| Mwyngil Therapeutics Inc. | May 2022 | Seed | Co-investor |
Key People
Rouslan Michtchenko
Director of Strategic Partnering and Investment
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is i2020 Accelerator based?
i2020 Accelerator is headquartered in San Diego, California, United States.
When was i2020 Accelerator founded?
i2020 Accelerator was founded in 2017.
How many portfolio companies does i2020 Accelerator have?
i2020 Accelerator has 2 portfolio companies in Caplight's dataset.
What are some companies in i2020 Accelerator's portfolio?
Portfolio companies visible on Caplight include Brenig Therapeutics, Mwyngil Therapeutics Inc..
What was i2020 Accelerator's most recent investment shown here?
i2020 Accelerator's most recent investment in this portfolio sample was in Mwyngil Therapeutics Inc. in 2022.
What sectors does i2020 Accelerator focus on?
i2020 Accelerator focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does i2020 Accelerator focus on?
i2020 Accelerator typically invests at the Early stage.